The estimated Net Worth of Anthony W Borowicz is at least $3.05 Milione dollars as of 31 December 2021. Mr. Borowicz owns over 658 units of Integer Corp stock worth over $2,732,382 and over the last 6 years he sold ITGR stock worth over $314,042. In addition, he makes $0 as Senior Vice President, Strategy e Corporate Development at Integer Corp.
Sign up
Mr. Borowicz ITGR stock SEC Form 4 insiders trading
Anthony has made over 6 trades of the Integer Corp stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 658 units of ITGR stock worth $81,757 on 31 December 2021.
The largest trade he's ever made was exercising 3,173 units of Integer Corp stock on 3 January 2020 worth over $394,245. On average, Anthony trades about 1,090 units every 114 days since 2019. As of 31 December 2021 he still owns at least 21,991 units of Integer Corp stock.
You can see the complete history of Mr. Borowicz stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Anthony Borowicz biography
Anthony W. Borowicz serves as Senior Vice President, Strategy, Corporate Development of the Company. He has has served in various leadership roles including Vice President, Business Development from December 2014 to December 2018 and Executive Director, Business Development from July 2013 to December 2014. Mr. Borowicz had served as the Vice President, Finance for Kendall Healthcare from April 2001 until joining the Company. Previously, he was the Vice President & Chief Financial Officer for Graphic Controls Corporation from January 1995 to April 2001.
How old is Anthony Borowicz?
Anthony Borowicz is 63, he's been the Senior Vice President, Strategy e Corporate Development of Integer Corp since 2018. There are 4 older and 21 younger executives at Integer Corp. The oldest executive at Integer Holdings Corp is Bill Sanford, 76, who is the Independent Chairman of the Board.
Insiders trading at Integer Corp
Over the last 8 years, insiders at Integer Corp have traded over $11,995,808 worth of Integer Corp stock and bought 28,350 units worth $1,274,625 . The most active insiders traders include Thomas J Hook, Filippo Passerini e Martin C Maxwell. On average, Integer Corp executives and independent directors trade stock every 14 days with the average trade being worth of $717,544. The most recent stock trade was executed by Diron Smith on 1 September 2024, trading 168 units of ITGR stock currently worth $20,874.
What does Integer Corp do?
integer holdings corporation (nyse:itgr) is a leader in advanced medical device outsourcing (mdo) and serves its customers by providing comprehensive end-to-end solutions with its unparalleled expertise in innovation and manufacturing. integer's vision is to enhance the lives of patients worldwide by being its customer's partner of choice for innovative medical technologies and services. additionally, through electrochem, an integer company, it develops custom batteries for high-end niche applications in energy, military, and environment markets. the company's medical device manufacturing brands include greatbatch™ medical and lake region medical™. additional information is available at www.integer.net.
What does Integer Corp's logo look like?
Complete history of Mr. Borowicz stock trades at Integer Corp
Integer Corp executives and stock owners
Integer Corp executives and other stock owners filed with the SEC include:
-
Joseph Dziedzic,
President, Chief Executive Officer, Director -
Joseph W. Dziedzic,
Pres, CEO & Director -
Jason Garland,
Chief Financial Officer, Executive Vice President -
Kirk Thor,
Chief Human Resource Officer, Executive Vice President -
Payman Khales,
President - Cardio and Vascular -
Jennifer Bolt,
Senior Vice President - Global Operations -
Joseph Flanagan,
Executive Vice President - Quality and Regulatory Affairs -
Jason K. Garland,
Exec. VP & CFO -
Payman Khales,
Pres of Cardio & Vascular -
Jennifer M. Bolt,
Sr. VP of Global Operations & ESG -
Joel D. Becker,
Pres of Cardiac Rhythm Management & Neuromodulation -
Bill Sanford,
Independent Chairman of the Board -
Jean Hobby,
Independent Director -
Martin Maxwell,
Independent Director -
Pamela Bailey,
Independent Director -
James Hinrichs,
Independent Director -
William Summers,
Independent Director -
Donald Spence,
Independent Director -
Filippo Passerini,
Independent Director -
Anthony Borowicz,
Senior Vice President, Strategy, Corporate Development -
Joel Becker,
President, CRM & Neuromodulation -
Margaret Carthy,
Sr. VP of Quality and Regulatory Affairs -
Kirk K. Thor,
Exec. VP & Chief HR Officer -
McAlister C. Marshall II,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Elizabeth K. Giddens,
Sr. VP, Gen. Counsel, Chief Ethics & Compliance Officer and Corp. Sec. -
Carter Houghton,
Pres of Portable Medical & Electrochem -
Margaret Carthy,
EVP, Qlty & Regulatory Affairs -
Jeremy Friedman,
EVP, COO -
Gary J Haire,
EVP & Chief Financial Officer -
Thomas J Hook,
President & CEO -
Declan Smyth,
Pres., Advanced Surgical, Orth -
Jose Antonio Gonzalez,
President, CRM & Neuro -
Peter H Soderberg,
Director -
Kristin Trecker,
Chief Human Resource Officer -
Timothy G Mc Evoy,
Sr. VP, Gen. Counsel & Sec. -
Thomas J Mazza,
VP, Corporate Controller -
John A Harris,
EVP, Global Ops and Manufactur -
Michael L Spencer,
Chief Ethics & Compliance Of -
Tommy P Thomas,
VP, Corporate Controller -
Diron Smith,
EVP, Chief Financial Officer -
Carter Houghton,
President, Electrochem -
Elizabeth Giddens,
SVP, General Counsel -
Jim Stephens,
President, CRM & Neuro -
Alvin Tyrone Jeffers,
Director -
Sheila Antrum,
Director -
Cheryl C Capps,
Director -
Mc Alister C Ii Marshall,
SVP, Gen Counsel & Secretary -
Andrew Senn,
SVP, Strategy and Business Dev